Keith Channon is the Chief Investigator of OxAMI. He is Professor of Cardiovascular Medicine at Oxford University and an Interventional Cardiologist at the John Radcliffe Hospital. He has extensive experience in Percutaneous Coronary Intervention (PCI ) and intravascular imaging and in atherosclerotic plaque and vascular biology. Keith Channon is Director of R&D at Oxford University Hospitals NHS Trust and Director of the NIHR Oxford Biomedical Research Centre.
Adrian Banning is an Interventional Cardiologist and Professor of Interventional Cardiology at Oxford University. He has an international reputation in PCI clinical trials, and in research relating PCI to myocardial injury. Adrian Banning is the President of the British Cardiac Intervention Society (BCIS), leads the ‘Oxford Live’ PCI teaching course each year and has national profile in PCI training and advanced techniques.
Raj Kharbanda is an Interventional Cardiologist at the John Radcliffe Hospital, and previously at Harefield Hospital. He has extensive experience in cardiac catheterization, PCI, radionuclide imaging DPD use and intravascular imaging with IVUS and OCT. Dr Kharbanda has a well-established background in clinical research in interventional cardiology and is an expert in inflammatory mediators and tissue injury after PCI.
Robin Choudhury is Professor of Cardiovascular Medicine in the University of Oxford, Clinical Director of the Oxford Acute Vascular Imaging Centre and Honorary Consultant / Interventional Cardiologist at the John Radcliffe Hospital and University of Oxford. He leads a research group that focuses on the characterisation and targeted modification of inflammation in vascular disease. He is Principal Investigator of the TriPartite Immunometabolism Consortium [TrIC] and has lead clinical trials in the fields of cholesterol modification and inflammation. He is co-Lead for the Cardiovascular Theme of the NIHR Oxford Biomedical Research Centre and Chair of the Atherothrombosis Clinical Study Group of the British Cardiovascular Society.
Vanessa Ferreira is Associate Professor of Cardiovascular Medicine at the University of Oxford and Honorary Consultant Cardiologist at the John Radcliffe Hospital. She is DeputyDirector of the Oxford Centre for Clinical Magnetic Resonance Research (OCMR). She is nationally and internationally recognised for her expertise in applications of cardiac magnetic resonance imaging in acute cardiac presentations with a particular scientific interest in novel imaging biomarkers.
Jeremy Langrish is an interventional cardiologist at the John Radcliffe Hospital and has extensive experience in cardiac catheterisation, PCI and intravascular imaging. He has a background in clinical research and a strong interest in vascular biology and mechanisms of vascular dysfunction.
Andrew Lucking is an Interventional Cardiologist at the John Radcliffe Hospital. He has extensive experience in cardiac catheterization and intervention, primary PCI, and intravascular imaging with IVUS and OCT. AL has a well-established background in clinical research in interventional cardiology and is an expert in inflammatory mediators, thrombosis, and vascular injury after PCI and STEMI.